Towards a multidisciplinary approach to understand and manage obesity and related diseases

Clinical Nutrition

Volumn 36, Issue 4, 2017, Pages 917-938

  Bischoff, Stephan C ^a   Boirie, Yves ^b   Cederholm, Tommy ^c   Chourdakis, Michael ^d   Cuerda, Cristina ^e   Delzenne, Nathalie M ^f   Deutz, Nicolaas E ^g   Fouque, Denis ^h   Genton, Laurence ⁱ   Gil, Carmen ^j   Koletzko, Berthold ^k   Leon Sanz, Miguel ^l   Shamir, Raanan ^m   Singer, Joelle ^m,n   Singer, Pierre ^m,n   Stroebele Benschop, Nanette ^a   Thorell, Anders ^o   Weimann, Arved ^p   Barazzoni, Rocco ^q  

^a UNIVERSITY OF HOHENHEIM   (Germany)

^b INRA and University of Auvergne   (France)

^c UPPSALA UNIVERSITY   (Sweden)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^g TEXAS A AND M UNIVERSITY   (United States)

^h CENTRE HOSPITALIER LYON SUD   (France)

ⁱ GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^j HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

^k LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^l UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^m TEL AVIV UNIVERSITY   (Israel)

ⁿ RABIN MEDICAL CENTER   (Israel)

^o ERSTA HOSPITAL   (Sweden)

^p Klinikum St Georg   (Germany)

^q UNIVERSITY OF TRIESTE   (Italy)

more..

Author keywords

Fatty liver disease; Metabolic syndrome; Microbiota; Multidisciplinary; Sarcopenic obesity; Weight maintenance

Indexed keywords

ADIPOSE TISSUE; ARTHROPATHY; BARIATRIC SURGERY; CHRONIC DISEASE; CLINICAL FEATURE; COMORBIDITY ASSESSMENT; DISEASE ASSOCIATION; FITNESS; HUMAN; INSULIN RESISTANCE; INTESTINE FLORA; LIFESTYLE MODIFICATION; LIPID STORAGE; MUSCLE MASS; OBESITY; OUTCOME ASSESSMENT; OVERNUTRITION; PATHOPHYSIOLOGY; PROGNOSIS; PUBLIC-PRIVATE PARTNERSHIP; QUALITY OF LIFE; REVIEW; SARCOPENIC OBESITY; SCREENING TEST; SEDENTARY LIFESTYLE; SKELETAL MUSCLE; WEIGHT REDUCTION; ANIMAL; BIOLOGICAL MODEL; BODY WEIGHT MAINTENANCE; CHILD; CHILDHOOD OBESITY; DYSBIOSIS; EVIDENCE BASED MEDICINE; GLOBAL HEALTH; METABOLIC SYNDROME X; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MUSCLE DEVELOPMENT; NONALCOHOLIC FATTY LIVER; PATIENT CARE; PERSONALIZED MEDICINE; SARCOPENIA; TRENDS;

ANIMALS; BODY WEIGHT MAINTENANCE; CHILD; CHRONIC DISEASE; COMBINED MODALITY THERAPY; DYSBIOSIS; EVIDENCE-BASED MEDICINE; GLOBAL HEALTH; HUMANS; METABOLIC SYNDROME; MIDDLE AGED; MODELS, BIOLOGICAL; MUSCLE DEVELOPMENT; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PATIENT CARE TEAM; PEDIATRIC OBESITY; PRECISION MEDICINE; PROGNOSIS; SARCOPENIA;

EID: 85007258148     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2016.11.007     Document Type: Review

References (232)

1. Cederholm, T.A.P., Ballmer, P., Barazzoni, R., Biolo, G., Bischoff, S.C., Holst, M., et al. Diagnostic and procedure related terminology of clinical nutrition – an ESPEN consensus guideline. Clin Nutr, 2016, 10.1016/j.clnu.2016.09.004 xx, in press.
2. Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M., Boirie, Y., Cederholm, T., Landi, F., et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on sarcopenia in older people. Age Ageing 39 (2010), 412–423.
3. Fielding, R.A., Vellas, B., Evans, W.J., Bhasin, S., Morley, J.E., Newman, A.B., et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12 (2011), 249–256.
4. Morley, J.E., Abbatecola, A.M., Argiles, J.M., Baracos, V., Bauer, J., Bhasin, S., et al. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 12 (2011), 403–409.
5. Stenholm, S., Harris, T.B., Rantanen, T., Visser, M., Kritchevsky, S.B., Ferrucci, L., Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 11 (2008), 693–700.
6. Zamboni, M., Mazzali, G., Fantin, F., Rossi, A., Di Francesco, V., Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis 18 (2008), 388–395.
7. Lissner, L., Sjostrom, L., Bengtsson, C., Bouchard, C., Larsson, B., The natural history of obesity in an obese population and associations with metabolic aberrations. Int J Obes Relat Metab Disord 18 (1994), 441–447.
8. Sowemimo, O.A., Yood, S.M., Courtney, J., Moore, J., Huang, M., Ross, R., et al. Natural history of morbid obesity without surgical intervention. Surg Obes Relat Dis 3 (2007), 73–77 discussion 7.
9. Swinburn, B.A., Sacks, G., Hall, K.D., McPherson, K., Finegood, D.T., Moodie, M.L., et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet 378 (2011), 804–814.
10. Hartz, A.J., Rimm, A.A., Natural history of obesity in 6,946 women between 50 and 59 years of age. Am J Public Health 70 (1980), 385–388.
11. Barazzoni, R., Van Gossum, A., Singer, P., Bischoff, S.C., Should ESPEN engage in facing the obesity challenge?. Clin Nutr 34 (2015), 169–170.
12. Glass, C.K., Olefsky, J.M., Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab 15 (2012), 635–645.
13. Muoio, D.M., Neufer, P.D., Lipid-induced mitochondrial stress and insulin action in muscle. Cell Metab 15 (2012), 595–605.
14. Inzucchi, S.E., Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med 355 (2006), 1903–1911.
15. Allan, C.A., McLachlan, R.I., Androgens and obesity. Curr Opin Endocrinol Diabetes Obes 17 (2010), 224–232.
16. Legro, R.S., Arslanian, S.A., Ehrmann, D.A., Hoeger, K.M., Murad, M.H., Pasquali, R., et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 98 (2013), 4565–4592.
17. Abraham, S.B., Rubino, D., Sinaii, N., Ramsey, S., Nieman, L.K., Cortisol, obesity, and the metabolic syndrome: a cross-sectional study of obese subjects and review of the literature. Obes (Silver Spring) 21 (2013), E105–E117.
18. Ouchi, N., Parker, J.L., Lugus, J.J., Walsh, K., Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11 (2011), 85–97.
19. DeMarco, V.G., Aroor, A.R., Sowers, J.R., The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol 10 (2014), 364–376.
20. Cernea, S., Raz, I., Therapy in the early stage: incretins. Diabetes Care 34:Suppl. 2 (2011), S264–S271.
21. Delhanty, P.J., Neggers, S.J., van der Lely, A.J., Mechanisms in endocrinology: ghrelin: the differences between acyl- and des-acyl ghrelin. Eur J Endocrinol 167 (2012), 601–608.
22. Ritze, Y., Hengelhaupt, C., Bárdos, G., Ernst, B., Thurnheer, M., D'Haese, J.G., et al. Altered intestinal neuroendocrine gene expression in humans with obesity. Obesity 23 (2015), 2278–2285.
23. Young, R.L., Lumsden, A.L., Keating, D.J., Gut serotonin is a regulator of obesity and metabolism. Gastroenterology 149 (2015), 253–255.
24. Jiang, C., Xie, C., Lv, Y., Li, J., Krausz, K.W., Shi, J., et al. Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction. Nat Commun, 6, 2015, 10166.
25. Cusi, K., Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology, 142, 2012 711–25.e6.
26. Michelotti, G.A., Machado, M.V., Diehl, A.M., NAFLD, NASH and liver cancer. Nat Rev Gastroenterol Hepatol 10 (2013), 656–665.
27. Kethu, S.R., Banerjee, S., Barth, B.A., Desilets, D.J., Kaul, V., Pedrosa, M.C., et al. Endoluminal bariatric techniques. Gastrointest Endosc 76 (2012), 1–7.
28. Wang, Y., Wang, Q.J., The prevalence of prehypertension and hypertension among US adults according to the New Joint National Committee Guidelines. Arch Intern Med, 164, 2004, 2126.
29. Tozawa, M., Iseki, K., Iseki, C., Oshiro, S., Ikemiya, Y., Takishita, S., Influence of smoking and obesity on the development of proteinuria. Kidney Int 62 (2002), 956–962.
30. Navarro-Diaz, M., Serra, A., Romero, R., Bonet, J., Bayes, B., Homs, M., et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol 17 (2006), S213–S217.
31. Hsu, C.-y., Body mass index and risk for end-stage renal disease. Ann Intern Med, 144, 2006, 21.
32. Mafra, D., Lobo, J.C., Barros, A.F., Koppe, L., Vaziri, N.D., Fouque, D., Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease. Future Microbiol 9 (2014), 399–410.
33. Koppe, L., Pelletier, C.C., Alix, P.M., Kalbacher, E., Fouque, D., Soulage, C.O., et al. Insulin resistance in chronic kidney disease: new lessons from experimental models. Nephrol Dial Transplant 29 (2013), 1666–1674.
34. Barros, A.F., Borges, N.A., Ferreira, D.C., Carmo, F.L., Rosado, A.S., Fouque, D., et al. Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients?. Future Microbiol 10 (2015), 517–526.
35. Mafra, D., Guebre-Egziabher, F., Fouque, D., Body mass index, muscle and fat in chronic kidney disease: questions about survival. Nephrol Dial Transplant 23 (2008), 2461–2466.
36. Hashimoto, Y., Tanaka, M., Okada, H., Senmaru, T., Hamaguchi, M., Asano, M., et al. Metabolically healthy obesity and risk of incident CKD. Clin J Am Soc Nephrol 10 (2015), 578–583.
37. Fouque, D., Kalantar-Zadeh, K., Kopple, J., Cano, N., Chauveau, P., Cuppari, L., et al. A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease. Kidney Int 73 (2007), 391–398.
38. Kovesdy, C.P., Anderson, J.E., Kalantar-Zadeh, K., Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis 49 (2007), 581–591.
39. Navaneethan, S.D., Yehnert, H., Moustarah, F., Schreiber, M.J., Schauer, P.R., Beddhu, S., Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol, 4, 2009, 10.
40. Hoogeveen, E.K., Aalten, J., Rothman, K.J., Roodnat, J.I., Mallat, M.J.K., Borm, G., et al. Effect of obesity on the outcome of kidney transplantation: a 20-year follow-up. Transplantation 91 (2011), 869–874.
41. Agostoni, C., Braegger, C., Decsi, T., Kolacek, S., Koletzko, B., Mihatsch, W., et al. Role of dietary factors and food habits in the development of childhood obesity: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 52 (2011), 662–669.
42. Ells, L.J., Mead, E., Atkinson, G., Corpeleijn, E., Roberts, K., Viner, R., et al. Surgery for the treatment of obesity in children and adolescents. Cochrane Database Syst Rev(6), 2015, 10.1002/14651858.CD011740 Wiley-Blackwell.
43. Cunningham, S.A., Kramer, M.R., Narayan, K.M.V., Incidence of childhood obesity in the United States. N Engl J Med 370 (2014), 403–411.
44. Lobstein, T., Jackson-Leach, R., Estimated burden of paediatric obesity and co-morbidities in Europe. Part 2. Numbers of children with indicators of obesity-related disease. Int J Pediatr Obes 1 (2006), 33–41.
45. Turck, D., Michaelsen, K.F., Shamir, R., Braegger, C., Campoy, C., Colomb, V., et al. World Health Organization 2006 child growth standards and 2007 growth reference charts. J Pediatr Gastroenterol Nutr 57 (2013), 258–264.
46. Oude Luttikhuis, H., Baur, L., Jansen, H., Shrewsbury, V.A., O'Malley, C., Stolk, R.P., et al. Interventions for treating obesity in children. Cochrane Database Syst Rev(1), 2009, 10.1002/14651858.CD001872.pub2 CD001872, Wiley-Blackwell.
47. Boland, C.L., Harris, J.B., Harris, K.B., Pharmacological management of obesity in pediatric patients. Ann Pharmacother 49 (2014), 220–232.
48. Scarborough, J.E., Bennett, K.M., Englum, B.R., Pappas, T.N., Lagoo-Deenadayalan, S.A., The impact of functional dependency on outcomes after complex general and vascular surgery. Ann Surg 261 (2015), 432–437.
49. Global BMIMC, Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet 388 (2016), 776–786.
50. Fukuda, Y., Yamamoto, K., Hirao, M., Nishikawa, K., Maeda, S., Haraguchi, N., et al. Prevalence of malnutrition among gastric cancer patients undergoing gastrectomy and optimal preoperative nutritional support for preventing surgical site infections. Ann Surg Oncol 22 (2015), 778–785.
51. McDermott, F.D., Heeney, A., Kelly, M.E., Steele, R.J., Carlson, G.L., Winter, D.C., Systematic review of preoperative, intraoperative and postoperative risk factors for colorectal anastomotic leaks. Br J Surg 102 (2015), 462–479.
52. Anderin, C., Gustafsson, U.O., Heijbel, N., Thorell, A., Weight loss before bariatric surgery and postoperative complications. Ann Surg 261 (2015), 909–913.
53. Carli, F., Scheede-Bergdahl, C., Prehabilitation to enhance perioperative care. Anesthesiol Clin 33 (2015), 17–33.
54. Mechanick, J.I., Youdim, A., Jones, D.B., Garvey, W.T., Hurley, D.L., McMahon, M.M., et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient–2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obes (Silver Spring), 21(Suppl. 1), 2013, 27.
55. Colquitt, J.L., Pickett, K., Loveman, E., Frampton, G.K., Surgery for weight loss in adults. Cochrane Database Syst Rev, 8(8), 2014 Aug, 10.1002/14651858.CD003641.pub4 CD003641, Wiley-Blackwell.
56. Schauer, D.P., Arterburn, D.E., Livingston, E.H., Coleman, K.J., Sidney, S., Fisher, D., et al. Impact of bariatric surgery on life expectancy in severely obese patients with diabetes. Ann Surg 261 (2015), 914–919.
57. Beebe, M.L., Crowley, N., Can hypocaloric, high-protein nutrition support be used in complicated bariatric patients to promote weight loss?. Nutr Clin Pract 30 (2015), 522–529.
58. Bischoff, S.C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., et al. Intestinal permeability – a new target for disease prevention and therapy. BMC Gastroenterol, 14, 2014, 189.
59. Ryan, D.H., Nonsurgical weight loss for extreme obesity in primary care settings. Arch Intern Med, 170, 2010, 146.
60. Flegal, K.M., Kit, B.K., Orpana, H., Graubard, B.I., Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. J Am Med Assoc 309 (2013), 71–82.
61. Oga, E.A., Eseyin, O.R., The obesity paradox and heart failure: a systematic review of a decade of evidence. J Obes, 2016, 2016, 9040248.
62. Biolo, G., Cederholm, T., Muscaritoli, M., Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. Clin Nutr 33 (2014), 737–748.
63. Dufour, A.B., Hannan, M.T., Murabito, J.M., Kiel, D.P., McLean, R.R., Sarcopenia definitions considering body size and fat mass are associated with mobility limitations: the Framingham Study. J Gerontol A Biol Sci Med Sci 68 (2013), 168–174.
64. Atkins, J.L., Whincup, P.H., Morris, R.W., Lennon, L.T., Papacosta, O., Wannamethee, S.G., Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc 62 (2014), 253–260.
65. Waters, D.L., Ward, A.L., Villareal, D.T., Weight loss in obese adults 65years and older: a review of the controversy. Exp Gerontol 48 (2013), 1054–1061.
66. Druml, W., ICU patients: fatter is better?. Intensive Care Med 34 (2008), 1961–1963.
67. McClave, S.A., Martindale, R.G., Vanek, V.W., McCarthy, M., Roberts, P., Taylor, B., et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). J Parenter Enteral Nutr 33 (2009), 277–316.
68. Kee, A.L., Isenring, E., Hickman, I., Vivanti, A., Resting energy expenditure of morbidly obese patients using indirect calorimetry: a systematic review. Obes Rev 13 (2012), 753–765.
69. Port, A.M., Apovian, C., Metabolic support of the obese intensive care unit patient: a current perspective. Curr Opin Clin Nutr Metab Care 13 (2010), 184–191.
70. Frankenfield, D.C., Ashcraft, C.M., Galvan, D.A., Prediction of resting metabolic rate in critically ill patients at the extremes of body mass index. J Parenter Enteral Nutr 37 (2013), 361–367.
71. Choban, P., Dickerson, R., Malone, A., Worthington, P., Compher, C., American Society for P, et al. A.S.P.E.N. Clinical guidelines: nutrition support of hospitalized adult patients with obesity. J Parenter Enteral Nutr 37 (2013), 714–744.
72. McClave, S.A., Kushner, R., Van Way, C.W. 3rd, Cave, M., DeLegge, M., Dibaise, J., et al. Nutrition therapy of the severely obese, critically ill patient: summation of conclusions and recommendations. J Parenter Enteral Nutr 35 (2011), 88S–96S.
73. Borel, A.L., Schwebel, C., Planquette, B., Vesin, A., Garrouste-Orgeas, M., Adrie, C., et al. Initiation of nutritional support is delayed in critically ill obese patients: a multicenter cohort study. Am J Clin Nutr 100 (2014), 859–866.
74. Harvey, S.E., Parrott, F., Harrison, D.A., Bear, D.E., Segaran, E., Beale, R., et al. Trial of the route of early nutritional support in critically ill adults. N Engl J Med 371 (2014), 1673–1684.
75. Teixeira, P.J., Carraça, E.V., Marques, M.M., Rutter, H., Oppert, J.-M., De Bourdeaudhuij, I., et al. Successful behavior change in obesity interventions in adults: a systematic review of self-regulation mediators. BMC Med, 2015, 13.
76. Jensen MD, Ryan DH, Donato KA, Apovian CM, Ard JD, Comuzzie AG, et al. Executive summary: guidelines (2013) for the management of overweight and obesity in adults. Obesity. 2014;22:S5–S39.
77. Kushner, R.F., Ryan, D.H., Assessment and lifestyle management of patients with obesity. J Am Med Assoc, 312, 2014, 943.
78. Mather, A.A., Cox, B.J., Enns, M.W., Sareen, J., Associations of obesity with psychiatric disorders and suicidal behaviors in a nationally representative sample. J Psychosom Res 66 (2009), 277–285.
79. Elias, M.F., Elias, P.K., Sullivan, L.M., Wolf, P.A., D'Agostino, R.B., Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord 27 (2003), 260–268.
80. Nousen, E.K., Franco, J.G., Sullivan, E.L., Unraveling the mechanisms responsible for the comorbidity between metabolic syndrome and mental health disorders. Neuroendocrinology 98 (2013), 254–266.
81. Li, Y., Dai, Q., Jackson, J.C., Zhang, J., Overweight is associated with decreased cognitive functioning among school-age children and adolescents. Obesity 16 (2008), 1809–1815.
82. Osika, W., Montgomery, S.M., Physical control and coordination in childhood and adult obesity: longitudinal birth cohort study. BMJ, 337, 2008 a699-a.
83. Smith, E., Hay, P., Campbell, L., Trollor, J.N., A review of the association between obesity and cognitive function across the lifespan: implications for novel approaches to prevention and treatment. Obes Rev 12 (2011), 740–755.
84. Gibson, E.L., The psychobiology of comfort eating. Behav Pharmacol 23 (2012), 442–460.
85. Miller, A.A., Spencer, S.J., Obesity and neuroinflammation: a pathway to cognitive impairment. Brain Behav Immun 42 (2014), 10–21.
86. Richard, D., Cognitive and autonomic determinants of energy homeostasis in obesity. Nat Rev Endocrinol 11 (2015), 489–501.
87. Ekelund, U., Besson, H., Luan, J., May, A.M., Sharp, S.J., Brage, S., et al. Physical activity and gain in abdominal adiposity and body weight: prospective cohort study in 288,498 men and women. Am J Clin Nutr 93 (2011), 826–835.
88. McAuley, P.A., Blair, S.N., Obesity paradoxes. J Sports Sci 29 (2011), 773–782.
89. Batsis, J.A., Mackenzie, T.A., Barre, L.K., Lopez-Jimenez, F., Bartels, S.J., Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III. Eur J Clin Nutr 68 (2014), 1001–1007.
90. Gonzalez, M.C., Pastore, C.A., Orlandi, S.P., Heymsfield, S.B., Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr 99 (2014), 999–1005.
91. Clark, B.C., Manini, T.M., What is dynapenia?. Nutrition 28 (2012), 495–503.
92. Hulens, M., Vansant, G., Lysens, R., Claessens, A.L., Muls, E., Brumagne, S., Study of differences in peripheral muscle strength of lean versus obese women: an allometric approach. Int J Obes Relat Metab Disord 25 (2001), 676–681.
93. Ruiz, J.R., Sui, X., Lobelo, F., Dc, Lee, Morrow, J.R., Jackson, A.W., et al. Muscular strength and adiposity as predictors of adulthood cancer mortality in men. Cancer Epidemiol Biomarkers Prev 18 (2009), 1468–1476.
94. Stenholm, S., Mehta, N.K., Elo, I.T., Heliövaara, M., Koskinen, S., Aromaa, A., Obesity and muscle strength as long-term determinants of all-cause mortality—a 33-year follow-up of the Mini-Finland Health Examination Survey. Int J Obes Relat Metab Disord 38 (2013), 1126–1132.
95. Kodama, S., Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women. J Am Med Assoc, 301, 2009, 2024.
96. Lavie, C.J., Cahalin, L.P., Chase, P., Myers, J., Bensimhon, D., Peberdy, M.A., et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc 88 (2013), 251–258.
97. Lee, D.-c., Sui, X., Church, T.S., Lavie, C.J., Jackson, A.S., Blair, S.N., Changes in fitness and fatness on the development of cardiovascular disease risk factors. J Am Coll Cardiol 59 (2012), 665–672.
98. Goel, K., Thomas, R.J., Squires, R.W., Coutinho, T., Trejo-Gutierrez, J.F., Somers, V.K., et al. Combined effect of cardiorespiratory fitness and adiposity on mortality in patients with coronary artery disease. Am Heart J 161 (2011), 590–597.
99. Ackerman, I.N., Osborne, R.H., Obesity and increased burden of hip and knee joint disease in Australia: results from a national survey. BMC Musculoskelet Disord, 13, 2012, 254.
100. Thijssen, E., van Caam, A., van der Kraan, P.M., Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritis. Rheumatology 54 (2014), 588–600.
101. Woolf, A.D., Breedveld, F., Kvien, T.K., Controlling the obesity epidemic is important for maintaining musculoskeletal health. Ann Rheum Dis 65 (2006), 1401–1402.
102. Grotle, M., Hagen, K.B., Natvig, B., Dahl, F.A., Kvien, T.K., Obesity and osteoarthritis in knee, hip and/or hand: an epidemiological study in the general population with 10 years follow-up. BMC Musculoskelet Disord, 9, 2008, 132.
103. Lievense, A.M., Influence of obesity on the development of osteoarthritis of the hip: a systematic review. Rheumatology 41 (2002), 1155–1162.
104. Sharma, L., Chang, A., Overweight: advancing our understanding of its impact on the knee and the hip. Ann Rheum Dis 66 (2006), 141–142.
105. Bergner, M., Bobbitt, R.A., Carter, W.B., Gilson, B.S., The sickness impact profile: development and final revision of a health status measure. Med Care 19 (1981), 787–805.
106. Kolotkin, R.L., Davidson, L.E., Crosby, R.D., Hunt, S.C., Adams, T.D., Six-year changes in health-related quality of life in gastric bypass patients versus obese comparison groups. Surg Obes Relat Dis 8 (2012), 625–633.
107. Warkentin, L.M., Das, D., Majumdar, S.R., Johnson, J.A., Padwal, R.S., The effect of weight loss on health-related quality of life: systematic review and meta-analysis of randomized trials. Obes Rev 15 (2013), 169–182.
108. Andersen, J.R., Aasprang, A., Karlsen, T.-I., Karin Natvig, G., Våge, V., Kolotkin, R.L., Health-related quality of life after bariatric surgery: a systematic review of prospective long-term studies. Surg Obes Relat Dis 11 (2015), 466–473.
109. Zogg, C.K., Mungo, B., Lidor, A.O., Stem, M., Rios Diaz, A.J., Haider, A.H., et al. Influence of body mass index on outcomes after major resection for cancer. Surgery 158 (2015), 472–485.
110. Karrowni, W., Kennedy, K., Jones, P., Valle, J., Abdallah, M., Daugherty, S., et al. Obesity paradox among survivors of acute myocardial infarction and its interaction with time. J Am Coll Cardiol, 65, 2015, A31.
111. Robinson, M.K., Mogensen, K.M., Casey, J.D., McKane, C.K., Moromizato, T., Rawn, J.D., et al. The relationship among obesity, nutritional status, and mortality in the critically ill. Crit Care Med 43 (2015), 87–100.
112. Franssen, F.M., Rutten, E.P., Groenen, M.T., Vanfleteren, L.E., Wouters, E.F., Spruit, M.A., New reference values for body composition by bioelectrical impedance analysis in the general population: results from the UK Biobank. J Am Med Dir Assoc, 15, 2014 448 e1–6.
113. Shulman, G.I., Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 371 (2014), 1131–1141.
114. He, J., Watkins, S., Kelley, D.E., Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 50 (2001), 817–823.
115. Delmonico, M.J., Harris, T.B., Visser, M., Park, S.W., Conroy, M.B., Velasquez-Mieyer, P., et al. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr 90 (2009), 1579–1585.
116. Tardif, N., Salles, J., Guillet, C., Tordjman, J., Reggio, S., Landrier, J.-F., et al. Muscle ectopic fat deposition contributes to anabolic resistance in obese sarcopenic old rats through eIF2α activation. Aging Cell 13 (2014), 1001–1011.
117. Guillet, C., Delcourt, I., Rance, M., Giraudet, C., Walrand, S., Bedu, M., et al. Changes in basal and insulin and amino acid response of whole body and skeletal muscle proteins in obese men. J Clin Endocrinol Metab 94 (2009), 3044–3050.
118. Masgrau, A., Mishellany-Dutour, A., Murakami, H., Beaufrère, A.-M., Walrand, S., Giraudet, C., et al. Time-course changes of muscle protein synthesis associated with obesity-induced lipotoxicity. J Physiol 590 (2012), 5199–5210.
119. Prado, C.M.M., Wells, J.C.K., Smith, S.R., Stephan, B.C.M., Siervo, M., Sarcopenic obesity: a critical appraisal of the current evidence. Clin Nutr 31 (2012), 583–601.
120. Kim, T.N., Park, M.S., Ryu, J.Y., Choi, H.Y., Hong, H.C., Yoo, H.J., et al. Impact of visceral fat on skeletal muscle mass and vice versa in a prospective cohort study: the Korean Sarcopenic Obesity Study (KSOS). PLoS One, 9, 2014, e115407.
121. Blüher, M., Mantzoros, C.S., From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century. Metabolism 64 (2015), 131–145.
122. Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114 (2004), 1752–1761.
123. Wu, J.H.Y., Cahill, L.E., Mozaffarian, D., Effect of fish oil on circulating adiponectin: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 98 (2013), 2451–2459.
124. Gustafson, B., Hedjazifar, S., Gogg, S., Hammarstedt, A., Smith, U., Insulin resistance and impaired adipogenesis. Trends Endocrinol Metab 26 (2015), 193–200.
125. Giordano, A., Smorlesi, A., Frontini, A., Barbatelli, G., Cinti, S., Mechanisms in endocrinology: white, brown and pink adipocytes: the extraordinary plasticity of the adipose organ. Eur J Endocrinol 170 (2014), R159–R171.
126. Cohen, P., Spiegelman, B.M., Brown and beige fat: molecular parts of a thermogenic machine. Diabetes 64 (2015), 2346–2351.
127. Hocking, S., Samocha-Bonet, D., Milner, K.-L., Greenfield, J.R., Chisholm, D.J., Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots. Endocr Rev 34 (2013), 463–500.
128. Nieuwdorp, M., Gilijamse, P.W., Pai, N., Kaplan, L.M., Role of the microbiome in energy regulation and metabolism. Gastroenterology 146 (2014), 1525–1533.
129. Geurts, L., Neyrinck, A.M., Delzenne, N.M., Knauf, C., Cani, P.D., Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. Benef Microbes 5 (2014), 3–17.
130. Bindels, L.B., Dewulf, E.M., Delzenne, N.M., GPR43/FFA2: physiopathological relevance and therapeutic prospects. Trends Pharmacol Sci 34 (2013), 226–232.
131. Tremaroli, V., Bäckhed, F., Functional interactions between the gut microbiota and host metabolism. Nature 489 (2012), 242–249.
132. Delzenne, N.M., Cani, P.D., Everard, A., Neyrinck, A.M., Bindels, L.B., Gut microorganisms as promising targets for the management of type 2 diabetes. Diabetologia 58 (2015), 2206–2217.
133. Spruss, A., Kanuri, G., Wagnerberger, S., Haub, S., Bischoff, S.C., Bergheim, I., Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 50 (2009), 1094–1104.
134. Damms-Machado, A., Mitra, S., Schollenberger, A.E., Kramer, K.M., Meile, T., Königsrainer, A., et al. Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. BioMed Res Int 2015 (2015), 1–12.
135. Shoaie, S., Ghaffari, P., Kovatcheva-Datchary, P., Mardinoglu, A., Sen, P., Pujos-Guillot, E., et al. Quantifying diet-induced metabolic changes of the human gut microbiome. Cell Metab 22 (2015), 320–331.
136. Marchesini, G., Petta, S., dale Grave, R., Diet, weight loss, and liver health in NAFLD: pathophysiology, evidence and practice. Hepatology 63 (2016), 2032–2043 n/a-n/a.
137. Yeh, M.M., Brunt, E.M., Pathological features of fatty liver disease. Gastroenterology 147 (2014), 754–764.
138. Ota, T., Takamura, T., Kurita, S., Matsuzawa, N., Kita, Y., Uno, M., et al. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. Gastroenterology 132 (2007), 282–293.
139. Seitz, H.K., Stickel, F., Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol Chem 387 (2006), 349–360.
140. Pischon, T., Boeing, H., Hoffmann, K., Bergmann, M., Schulze, M.B., Overvad, K., et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 359 (2008), 2105–2120.
141. Stefan, N., Identification and characterization of metabolically benign obesity in humans. Arch Intern Med, 168, 2008, 1609.
142. Després, J.-P., Lemieux, I., Abdominal obesity and metabolic syndrome. Nature 444 (2006), 881–887.
143. Ritze, Y., Bárdos, G., Claus, A., Ehrmann, V., Bergheim, I., Schwiertz, A., et al. Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice. PLoS One, 9, 2014, e80169.
144. Spruss, A., Kanuri, G., Stahl, C., Bischoff, S.C., Bergheim, I., Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function. Lab Invest 92 (2012), 1020–1032.
145. Volynets, V., Küper, M.A., Strahl, S., Maier, I.B., Spruss, A., Wagnerberger, S., et al. Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD). Dig Dis Sci 57 (2012), 1932–1941.
146. Volynets, V., Machann, J., Küper, M.A., Maier, I.B., Spruss, A., Königsrainer, A., et al. A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study. Eur J Nutr 52 (2012), 527–535.
147. Casas-Vara, A., Santolaria, F., Fernández-Bereciartúa, A., González-Reimers, E., García-Ochoa, A., Martínez-Riera, A., The obesity paradox in elderly patients with heart failure: analysis of nutritional status. Nutrition 28 (2012), 616–622.
148. Kalantar-Zadeh, K., Streja, E., Molnar, M.Z., Lukowsky, L.R., Krishnan, M., Kovesdy, C.P., et al. Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis. Am J Epidemiol 175 (2012), 793–803.
149. Wannamethee, S.G., Shaper, A.G., Whincup, P.H., Lennon, L., Papacosta, O., Sattar, N., The obesity paradox in men with coronary heart disease and heart failure: the role of muscle mass and leptin. Int J Cardiol 171 (2014), 49–55.
150. Engelen, M.P.K.J., Com, G., Anderson, P.J., Deutz, N.E.P., New stable isotope method to measure protein digestibility and response to pancreatic enzyme intake in cystic fibrosis. Clin Nutr 33 (2014), 1024–1032.
151. Anderson, E.J., Sylvia, L.G., Lynch, M., Sonnenberg, L., Lee, H., Nathan, D.M., Comparison of energy assessment methods in overweight individuals. J Acad Nutr Diet 114 (2014), 273–278.
152. Wilms, B., Ernst, B., Thurnheer, M., Weisser, B., Schultes, B., Correction factors for the calculation of metabolic equivalents (MET) in overweight to extremely obese subjects. Int J Obes Relat Metab Disord 38 (2014), 1383–1387.
153. Rotella, C.M., Measurement of body composition as a surrogate evaluation of energy balance in obese patients. WJM, 5, 2015, 1.
154. Friedrich, A.E., Damms-Machado, A., Meile, T., Scheuing, N., Stingel, K., Basrai, M., et al. Laparoscopic sleeve gastrectomy compared to a multidisciplinary weight loss program for obesity—effects on body composition and protein status. Obes Surg 23 (2013), 1957–1965.
155. Pietiläinen, K.H., Kaye, S., Karmi, A., Suojanen, L., Rissanen, A., Virtanen, K.A., Agreement of bioelectrical impedance with dual-energy X-ray absorptiometry and MRI to estimate changes in body fat, skeletal muscle and visceral fat during a 12-month weight loss intervention. Br J Nutr 109 (2012), 1910–1916.
156. Cawthon, P.M., Blackwell, T.L., Cauley, J., Kado, D.M., Barrett-Connor, E., Lee, C.G., et al. Evaluation of the usefulness of consensus definitions of sarcopenia in older men: results from the observational osteoporotic fractures in men cohort study. J Am Geriatr Soc 63 (2015), 2247–2259.
157. Muscaritoli, M., Anker, S.D., Argilés, J., Aversa, Z., Bauer, J.M., Biolo, G., et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29 (2010), 154–159.
158. Bosy-Westphal, A., Müller, M.J., Identification of skeletal muscle mass depletion across age and BMI groups in health and disease—there is need for a unified definition. Int J Obes Relat Metab Disord 39 (2014), 379–386.
159. Kyle, U.G., Pirlich, M., Lochs, H., Schuetz, T., Pichard, C., Increased length of hospital stay in underweight and overweight patients at hospital admission: a controlled population study. Clin Nutr 24 (2005), 133–142.
160. Norman, K., Stobäus, N., Gonzalez, M.C., Schulzke, J.-D., Pirlich, M., Hand grip strength: outcome predictor and marker of nutritional status. Clin Nutr 30 (2011), 135–142.
161. Guralnik, J.M., Simonsick, E.M., Ferrucci, L., Glynn, R.J., Berkman, L.F., Blazer, D.G., et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 49 (1994), M85–M94.
162. Jensen, M.D., Ryan, D.H., Apovian, C.M., Ard, J.D., Comuzzie, A.G., Donato, K.A., et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults. Circulation 129 (2013), S102–S138.
163. Standards of medical care in diabetes–2014. Diabetes Care 37:Suppl. 1 (2014), S14–S80.
164. Diagnosis and classification of diabetes mellitus. Diabetes Care 37:Suppl. 1 (2014), S81–S90 Diabetes Care. 2014;37:887.
165. Goff, D.C., Lloyd-Jones, D.M., Bennett, G., Coady, S., D'Agostino, R.B., Gibbons, R., et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. J Am Coll Cardiol 63 (2014), 2935–2959.
166. Sharma, A.M., Kushner, R.F., A proposed clinical staging system for obesity. Int J Obes Relat Metab Disord 33 (2009), 289–295.
167. Pereira-Santos, M., Costa, P.R.F., Assis, A.M.O., Santos, C.A.S.T., Santos, D.B., Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev 16 (2015), 341–349.
168. García, O.P., Effect of vitamin A deficiency on the immune response in obesity. Proc Nutr Soc 71 (2012), 290–297.
169. da Silva, V.R., Hausman, D.B., Kauwell, G.P.A., Sokolow, A., Tackett, R.L., Rathbun, S.L., et al. Obesity affects short-term folate pharmacokinetics in women of childbearing age. Int J Obes Relat Metab Disord 37 (2013), 1608–1610.
170. Damms-Machado, A., Friedrich, A., Kramer, K.M., Stingel, K., Meile, T., Küper, M.A., et al. Pre- and postoperative nutritional deficiencies in obese patients undergoing laparoscopic sleeve gastrectomy. Obes Surg 22 (2012), 881–889.
171. Damms-Machado, A., Weser, G., Bischoff, S.C., Micronutrient deficiency in obese subjects undergoing low calorie diet. Nutr J, 11, 2012, 34.
172. Schollenberger, A.E., Heinze, J.M., Meile, T., Peter, A., Königsrainer, A., Bischoff, S.C., Markers of bone metabolism in obese individuals undergoing laparoscopic sleeve gastrectomy. Obes Surg 25 (2014), 1439–1445.
173. Soares, M.J., Chan She Ping-Delfos, W., Ghanbari, M.H., Calcium and vitamin D for obesity: a review of randomized controlled trials. Eur J Clin Nutr 65 (2011), 994–1004.
174. Stein, J., Stier, C., Raab, H., Weiner, R., Review article: the nutritional and pharmacological consequences of obesity surgery. Aliment Pharmacol Ther 40 (2014), 582–609.
175. Kurth, B.M., Schaffrath Rosario, A., The prevalence of overweight and obese children and adolescents living in Germany. Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Bundesgesundheitsblatt Gesundheitsforsch Gesundheitsschutz 50 (2007), 736–743.
176. Bayer, O., von Kries, R., Strauss, A., Mitschek, C., Toschke, A.M., Hose, A., et al. Short- and mid-term effects of a setting based prevention program to reduce obesity risk factors in children: a cluster-randomized trial. Clin Nutr 28 (2009), 122–128.
177. Duvinage, K., Ibrügger, S., Kreichauf, S., Wildgruber, A., De Craemer, M., De Decker, E., et al. Developing the intervention material to increase physical activity levels of European preschool children: the ToyBox-study. Obes Rev 15 (2014), 27–39.
178. Brands, B., Demmelmair, H., Koletzko, B., How growth due to infant nutrition influences obesity and later disease risk. Acta Paediatr 103 (2014), 578–585.
179. Koletzko, B., Brands, B., Chourdakis, M., Cramer, S., Grote, V., Hellmuth, C., et al. The power of programming and the EarlyNutrition project: opportunities for health promotion by nutrition during the first thousand days of life and beyond. Ann Nutr Metab 64 (2014), 187–196.
180. Koletzko, B., Symonds, M.E., Olsen, S.F., Programming research: where are we and where do we go from here?. Am J Clin Nutr 94 (2011), 2036S–2043S.
181. Dodd, J.M., Turnbull, D., McPhee, A.J., Deussen, A.R., Grivell, R.M., Yelland, L.N., et al. Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. BMJ, 348, 2014 g1285-g.
182. Koletzko, B., Chourdakis, M., Grote, V., Hellmuth, C., Prell, C., Rzehak, P., et al. Regulation of early human growth: impact on long-term health. Ann Nutr Metab 65 (2014), 101–109.
183. Koletzko, B., von Kries, R., Monasterolo, R.C., Subias, J.E., Scaglioni, S., Giovannini, M., et al. Infant feeding and later obesity risk. Adv Exp Med Biol 646 (2009), 15–29 Springer Science + Business Media.
184. Arenz, S., Rückerl, R., Koletzko, B., von Kries, R., Breast-feeding and childhood obesity—a systematic review. Int J Obes Relat Metab Disord 28 (2004), 1247–1256.
185. Horta, B.L., Loret de Mola, C., Victora, C.G., Long-term consequences of breastfeeding on cholesterol, obesity, systolic blood pressure and type 2 diabetes: a systematic review and meta-analysis. Acta Paediatr Suppl 104 (2015), 30–37.
186. Yan, J., Liu, L., Zhu, Y., Huang, G., Wang, P., The association between breastfeeding and childhood obesity: a meta-analysis. BMC Public Health, 14, 2014, 1267.
187. Koletzko, B., von Kries, R., Closa, R., Escribano, J., Scaglioni, S., Giovannini, M., et al. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. Am J Clin Nutr 89 (2009), 1836–1845.
188. Weber, M., Grote, V., Closa-Monasterolo, R., Escribano, J., Langhendries, J.P., Dain, E., et al. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. Am J Clin Nutr 99 (2014), 1041–1051.
189. Hoelscher, D.M., Kirk, S., Ritchie, L., Cunningham-Sabo, L., Position of the academy of nutrition and dietetics: interventions for the prevention and treatment of pediatric overweight and obesity. J Acad Nutr Diet 113 (2013), 1375–1394.
190. Butryn, M.L., Phelan, S., Hill, J.O., Wing, R.R., Consistent self-monitoring of weight: a key component of successful weight loss maintenance. Obesity 15 (2007), 3091–3096.
191. Steinberg, D.M., Bennett, G.G., Askew, S., Tate, D.F., Weighing every day matters: daily weighing improves weight loss and adoption of weight control behaviors. J Acad Nutr Diet 115 (2015), 511–518.
192. Dixon, H., Scully, M., Durkin, S., Brennan, E., Cotter, T., Maloney, S., et al. Finding the keys to successful adult-targeted advertisements on obesity prevention: an experimental audience testing study. BMC Public Health, 2015, 15.
193. Comans, T.A., Whitty, J.A., Hills, A.P., Kendall, E., Turkstra, E., Gordon, L.G., et al. The cost-effectiveness and consumer acceptability of taxation strategies to reduce rates of overweight and obesity among children in Australia: study protocol. BMC Public Health, 13, 2013, 1182.
194. Abete, I., Astrup, A., Martínez, J.A., Thorsdottir, I., Zulet, M.A., Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance. Nutr Rev 68 (2010), 214–231.
195. Aller, E.E.J.G., Larsen, T.M., Claus, H., Lindroos, A.K., Kafatos, A., Pfeiffer, A., et al. Weight loss maintenance in overweight subjects on ad libitum diets with high or low protein content and glycemic index: the DIOGENES trial 12-month results. Int J Obes Relat Metab Disord 38 (2014), 1511–1517.
196. Pirozzo, S., Summerbell, C., Cameron, C., Glasziou, P., Advice on low-fat diets for obesity. Protocols(2), 2002 CD003640, Wiley-Blackwell.
197. Hooper, L., Abdelhamid, A., Moore, H.J., Douthwaite, W., Skeaff, C.M., Summerbell, C.D., Effect of reducing total fat intake on body weight: systematic review and meta-analysis of randomised controlled trials and cohort studies. BMJ, 345, 2012 e7666-e.
198. Te Morenga, L., Mallard, S., Mann, J., Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ, 346, 2012 e7492-e.
199. Kosoglou, T., Hubbell, J., Cutler, D.L., Johnson-Levonas, A.O., Xu, D., Kantesaria, B.S., et al. Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhaler. Chest, 144, 2013, 1795.
200. Malik, V.S., Pan, A., Willett, W.C., Hu, F.B., Sugar-sweetened beverages and weight gain in children and adults: a systematic review and meta-analysis. Am J Clin Nutr 98 (2013), 1084–1102.
201. Abargouei, A.S., Janghorbani, M., Salehi-Marzijarani, M., Esmaillzadeh, A., Effect of dairy consumption on weight and body composition in adults: a systematic review and meta-analysis of randomized controlled clinical trials. Int J Obes Relat Metab Disord 36 (2012), 1485–1493.
202. Chen, M., Pan, A., Malik, V.S., Hu, F.B., Effects of dairy intake on body weight and fat: a meta-analysis of randomized controlled trials. Am J Clin Nutr 96 (2012), 735–747.
203. Thomas, D., Elliott, E.J., Baur, L., Low glycaemic index or low glycaemic load diets for overweight and obesity. Cochrane Database Syst Rev(3), 2007 CD005105, Wiley-Blackwell.
204. Hauner, H., Moss, A., Berg, A., Bischoff, S.C., Colombo-Benkmann, M., Ellrott, T., et al. Interdisciplinary guideline of S3 quality on prevention and therapy of obesity. Adipositas 8 (2014), 179–221.
205. NICE, Weight management: lifestyle services for overweight or obese adults. NICE guidelines [PH53], 2014.
206. SIGN, Management of obesity. SIGN guideline 115, 2010.
207. Bischoff, S.C., Damms-Machado, A., Betz, C., Herpertz, S., Legenbauer, T., Löw, T., et al. Multicenter evaluation of an interdisciplinary 52-week weight loss program for obesity with regard to body weight, comorbidities and quality of life—a prospective study. Int J Obes Relat Metab Disord 36 (2011), 614–624.
208. Furlow, E.A., Anderson, J.W., A systematic review of targeted outcomes associated with a medically supervised commercial weight-loss program. J Am Diet Assoc 109 (2009), 1417–1421.
209. Hemmingsson, E., Johansson, K., Eriksson, J., Sundstrom, J., Neovius, M., Marcus, C., Weight loss and dropout during a commercial weight-loss program including a very-low-calorie diet, a low-calorie diet, or restricted normal food: observational cohort study. Am J Clin Nutr 96 (2012), 953–961.
210. Bazzano, L.A., Hu, T., Reynolds, K., Yao, L., Bunol, C., Liu, Y., et al. Effects of low-carbohydrate and low-fat diets. Ann Intern Med, 161, 2014, 309.
211. Miller, C.T., Fraser, S.F., Levinger, I., Straznicky, N.E., Dixon, J.B., Reynolds, J., et al. The effects of exercise training in addition to energy restriction on functional capacities and body composition in obese adults during weight loss: a systematic review. PLoS One, 8, 2013, e81692.
212. Astrup, A., Rossner, S., Lessons from obesity management programmes: greater initial weight loss improves long-term maintenance. Obes Rev 1 (2000), 17–19.
213. Purcell, K., Sumithran, P., Prendergast, L.A., Bouniu, C.J., Delbridge, E., Proietto, J., The effect of rate of weight loss on long-term weight management: a randomised controlled trial. Lancet Diabetes Endocrinol 2 (2014), 954–962.
214. Ross Middleton, K.M., Patidar, S.M., Perri, M.G., The impact of extended care on the long-term maintenance of weight loss: a systematic review and meta-analysis. Obes Rev 13 (2011), 509–517.
215. Puzziferri, N., Roshek, T.B., Mayo, H.G., Gallagher, R., Belle, S.H., Livingston, E.H., Long-term follow-up after bariatric surgery. J Am Med Assoc, 312, 2014, 934.
216. Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351 (2004), 2683–2693.
217. Apovian, C.M., Aronne, L.J., Bessesen, D.H., McDonnell, M.E., Murad, M.H., Pagotto, U., et al. Pharmacological management of obesity: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 100 (2015), 342–362.
218. Jones, B.J., Bloom, S.R., The new era of drug therapy for obesity: the evidence and the expectations. Drugs 75 (2015), 935–945.
219. Yanovski, S.Z., Yanovski, J.A., Long-term drug treatment for obesity. J Am Med Assoc, 311, 2014, 74.
220. Bray, G.A., Ryan, D.H., Medical therapy for the patient with obesity. Circulation 125 (2012), 1695–1703.
221. Dhurandhar, E.J., Keith, S.W., The aetiology of obesity beyond eating more and exercising less. Best Pract Res Clin Gastroenterol 28 (2014), 533–544.
222. Tang-Peronard, J.L., Andersen, H.R., Jensen, T.K., Heitmann, B.L., Endocrine-disrupting chemicals and obesity development in humans: a review. Obes Rev 12 (2011), 622–636.
223. Buchwald, H., Oien, D.M., Metabolic/bariatric surgery worldwide 2011. Obes Surg 23 (2013), 427–436.
224. Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Leccesi, L., et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366 (2012), 1577–1585.
225. Schauer, P.R., Kashyap, S.R., Wolski, K., Brethauer, S.A., Kirwan, J.P., Pothier, C.E., et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366 (2012), 1567–1576.
226. Brethauer, S.A., Aminian, A., Romero-Talamás, H., Batayyah, E., Mackey, J., Kennedy, L., et al. Can diabetes Be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg, 2013, 1.
227. Romeo, S., Maglio, C., Burza, M.A., Pirazzi, C., Sjoholm, K., Jacobson, P., et al. Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. Diabetes Care 35 (2012), 2613–2617.
228. Sjöström, L., Peltonen, M., Jacobson, P., Sjöström, C.D., Karason, K., Wedel, H., et al. Bariatric surgery and long-term cardiovascular events. J Am Med Assoc, 307, 2012, 56.
229. Iaconelli, A., Panunzi, S., De Gaetano, A., Manco, M., Guidone, C., Leccesi, L., et al. Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care 34 (2011), 561–567.
230. Driscoll, S., Gregory, D.M., Fardy, J.M., Twells, L.K., Long-term health-related quality of life in bariatric surgery patients: a systematic review and meta-analysis. Obesity 24 (2015), 60–70.
231. Genton, L., Calorie and macronutrient requirements for physical fitness. E-spen, 2011, e77–e84.
232. Garber, C.E., Blissmer, B., Deschenes, M.R., Franklin, B.A., Lamonte, M.J., Lee, I.M., et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 43 (2011), 1334–1359.